106 results
Urgency is not an emergency. Using IV drugs for hypertensive urgency can lead to more harm
Hypertensive #Urgency #Guidelines ... #Timeframe #Reduction
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Initial Laboratory Workup ... COVID-19 Specific Medications ... #criticalcare #Guidelines
Standardized Physical Abuse Guideline
<6 months of age
 • Social work consult
 • Skeletal survey
 • Head
Physical Abuse Guideline ... age • Social work ... Physical #Abuse #Guidelines ... #Workup #Peds #
Algorithm for the differentiation between simple and complex febrile seizures. Guidelines for evaluation of each. #Diagnosis
Guidelines for evaluation ... Seizure #Algorithm #Workup
Management of type 2 diabetes in adults: summary of updated NICE guidance
#diabetes #type2 #DM2 #management #NICE
management #NICE #guidelines ... #medications #insulin
Initial triage of the neutropenic adult - Algorithm for the evaluation and treatment of adult patients
neutropenia #Algorithm #workup ... hematology #biopsy #indications
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA Guidelines ... pharmacology #dosing #medications ... #IDSA #Guidelines
COVID-19 Hypoxia Management

Indication for endotracheal intubation?
Tolerating supplemental oxygen?
Consider HFNC
Not tolerating HFNC or HFNC is not available?
Consider
Management Indication ... Consider Indication ... Surviving Sepsis Guidelines ... survivingsepsis #guidelines
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup ... Management - IDSA Guidelines ... Additional metastatic workup ... Candidemia #IDSA #Guidelines
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... exacerbations. 2019 GOLD guidelines ... #Roflumilast #Indications